EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Update and Drug Target in Molecular and Pharmacological Insights into Autophagy Modulation in Cancer Treatment and Future Progress

Md Ataur Rahman iD, Abu Saim Mohammad Saikat iD, Md Saidur Rahman iD, Mobinul Islam, Md Anowar Khasru Parvez iD, Bonglee Kim iD

Cells · 2023

DOI: 10.3390/cells12030458 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2023. Verfasst von Md Ataur Rahman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, College of Korean Medicine, Kyung Hee University, 1-5 Hoegidong Dongdaemun-gu, Seoul 02447, Republic of Korea. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, Basic Science Research Program through the National Research Foundation of Korea (NRF), Ministry of Health and Welfare, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent evidence suggests that autophagy is a governed catabolic framework enabling the recycling of nutrients from injured organelles and other cellular constituents via a lysosomal breakdown. This mechanism has been associated with the development of various pathologic conditions, including cancer and neurological disorders; however, recently updated studies have indicated that autophagy plays a dual role in cancer, acting as a cytoprotective or cytotoxic mechanism. Numerous preclinical and clinical investigations have shown that inhibiting autophagy enhances an anticancer medicine’s effectiveness in various malignancies. Autophagy antagonists, including chloroquine and hydroxychloroquine, have previously been authorized in clinical trials, encouraging the development of medication-combination therapies targeting the autophagic processes for cancer. In this review, we provide an update on the recent research examining the anticancer efficacy of combining drugs that activate cytoprotective autophagy with autophagy inhibitors. Additionally, we highlight the difficulties and progress toward using cytoprotective autophagy targeting as a cancer treatment strategy. Importantly, we must enable the use of suitable autophagy inhibitors and coadministration delivery systems in conjunction with anticancer agents. Therefore, this review briefly summarizes the general molecular process behind autophagy and its bifunctional role that is important in cancer suppression and in encouraging tumor growth and resistance to chemotherapy and metastasis regulation. We then emphasize how autophagy and cancer cells interacting with one another is a promising therapeutic target in cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsNeoplasmsHumansChloroquineHydroxychloroquineAutophagy

Stichwörter der Autor:innen

autophagic cell deathautophagyautophagy activatorsautophagy inhibitorscancer

Substanzen

Antineoplastic AgentsChloroquineHydroxychloroquine

Autor:innen und Institutionen

  • Department of Pathology, College of Korean Medicine, Kyung Hee University, 1-5 Hoegidong Dongdaemun-gu, Seoul 02447, Republic of Korea.
  • Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
  • Department of Biochemistry and Molecular Biology, Life Science Faculty, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj 8100, Bangladesh.
  • Department of Animal Science & Technology and BET Research Institute, Chung-Ang University, Anseong 17546, Republic of Korea.
  • Department of Energy and Materials Engineering, Dongguk University, Seoul 04620, Republic of Korea.
  • Department of Microbiology, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh.

ORCID-Profile: Md Ataur Rahman, Abu Saim Mohammad Saikat, Md Saidur Rahman, Md Anowar Khasru Parvez, Bonglee Kim

Förderung

  • NIEHS NIH HHS
  • Basic Science Research Program through the National Research Foundation of Korea (NRF)
  • Ministry of Health and Welfare, Republic of Korea

Zitieren

APA

Rahman, M. A., Saikat, A. S. M., Rahman, M. S., Islam, M., Parvez, M. A. K., & Kim, B. (2023). Recent Update and Drug Target in Molecular and Pharmacological Insights into Autophagy Modulation in Cancer Treatment and Future Progress. Cells. https://doi.org/10.3390/cells12030458

Vancouver

Rahman MA, Saikat ASM, Rahman MS, Islam M, Parvez MAK, Kim B. Recent Update and Drug Target in Molecular and Pharmacological Insights into Autophagy Modulation in Cancer Treatment and Future Progress. Cells. 2023. doi:10.3390/cells12030458

BibTeX
@article{Rahman2023,
  author = {Rahman, Md Ataur and Saikat, Abu Saim Mohammad and Rahman, Md Saidur and Islam, Mobinul and Parvez, Md Anowar Khasru and Kim, Bonglee},
  title = {Recent Update and Drug Target in Molecular and Pharmacological Insights into Autophagy Modulation in Cancer Treatment and Future Progress},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12030458}
}
Kostenlos starten →